KS

Kripa Shankar Shukla

Active Director Director DIN 10555657
DIN 10555657 First appointment Mar 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Kripa Shankar Shukla

Data last updated:

Kripa Shankar Shukla is a Director at Vechur Pharma Private Limited (since 2024). Vechur Pharma Private Limited reported revenue of ₹9.6 Lakh (FY 2026).

DIN 10555657
Primary Designation Director
First Appointment 19 Mar 2024
Oldest Company Age 2 yrs
Largest company Vechur Pharma Private Limited · ₹9.6 Lakh (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vechur Pharma Private Limited U46497UP2024PTC199594
Director19 Mar 20242024₹9.6 Lakh (FY 2026)Active

Board colleagues of Kripa Shankar Shukla

NameDINCompanyDesignation
Amit Kumar Shukla10555658Vechur Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vechur Pharma Private Limited
Premium access

Shareholding and investment profile for Kripa Shankar Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kripa Shankar Shukla

Kripa Shankar Shukla currently holds 1 directorship: Vechur Pharma Private Limited (Director, since 19 Mar 2024, revenue ₹9.6 Lakh (FY 2026)).

Kripa Shankar Shukla was first appointed on 19 Mar 2024 as Director at Vechur Pharma Private Limited.

The current boards of Kripa Shankar Shukla's companies include Amit Kumar Shukla (Vechur Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available